The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders-Reference-Cited by-同舟云学术

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders

Published:2006 Issue:4 Volume:107 Page:773-780
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Polizzotto Mark N.,Tam Constantine S.,Milner Alvin,Januszewicz E. Henry,Prince H. Miles,Westerman David,Wolf Max M.,Seymour John F.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference56 articles.

1. Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995

2. Changing incidence of non-Hodgkin lymphomas in the United States

3. Trends in leukemia incidence and survival in the United States (1973–1998)

4. Leukemias, myeloma, and other lymphoreticular neoplasms

5. Chronic lymphocytic leukaemia at a county hospital in southern Sweden

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients;Indian Journal of Hematology and Blood Transfusion;2022-05-27

2. Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy;Leukemia & Lymphoma;2015-11-20

3. How applicable is fludarabine, cyclophosphamide and rituximab to the elderly?;Leukemia & Lymphoma;2014-11-20

4. De novoB-cell prolymphocytic leukemia with central nervous system involvement;Leukemia & Lymphoma;2014-04-29

5. Fludarabine: A review of the clear benefits and potential harms;Leukemia Research;2013-09